1,3 disubstituted pyrrolidines as α-2-adrenoceptor...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S208000, C546S276400, C548S125000, C548S126000, C548S127000, C514S361000

Reexamination Certificate

active

07012085

ABSTRACT:
The invention provides compounds of formula (I) wherein R0, R1, R2and A are as defined in the description, and the preparation thereof. The compounds of formula (I) have high affinity as α2adrenoceptors and hence are useful as pharmaceuticals.

REFERENCES:
patent: 5185364 (1993-02-01), Debernardis et al.
patent: 5407946 (1995-04-01), Lavielle et al.
patent: 296560 (1988-12-01), None
patent: WO 92 18475 (1992-10-01), None
patent: WO 92/22527 (1992-12-01), None
patent: WO 95/24391 (1995-09-01), None
patent: WO 00 03714 (2000-01-01), None
patent: WO 00/27815 (2000-05-01), None
(Chemical Abstracts, Abstract No. 3995b, A.V.El′tsov et al., “N-Aralkyl Derivatives of Phenylpyrrolidines”, vol. 34, No. 10, pp. 3344-3351 (1964) (XP 002164442).
Ahn, Kyo Han et al., Bioorg.Med.Chem.Lett., vol. 9, No. 10, pp. 1379-1384 (1999) (XP 004164896).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1,3 disubstituted pyrrolidines as α-2-adrenoceptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,3 disubstituted pyrrolidines as α-2-adrenoceptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,3 disubstituted pyrrolidines as α-2-adrenoceptor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3595628

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.